THERANEXUS AND BBDF PRESENT PROGRESS ON THE BATTEN-1 PROGRAM AT THE TRANSLATIONAL RESEARCH CONFERENCE FOR THE MANAGEMENT OF NCLS ON 3 AND 4 NOVEMBER, 2022 IN CHICAGO

Lyon, France - Austin, Texas, United States - 2 November 2022 - 6pm CET - Theranexus, a biopharmaceutical company innovating in the treatment of neurological diseases and pioneer in the development

Related Keywords

United States ,Paris ,France General ,France ,Texas ,French ,Thierry Lambert ,Mathieu Charv ,Florence Portejoie ,Martin Pierre Laurent ,Emyr Lloyd Evans ,Cardiff University School Of Biosciences ,National Organization For Rare Disorders ,Translational Research Conference For The Management ,Twitter ,Atomic Energy Commission ,Batten Disease Foundation ,Beyond Batten Disease Foundation ,Cardiff University ,Translational Research Conference ,Cardiff University School ,Chief Scientific Officer ,French Alternative Energies ,Euronext Growth ,Rare Disorders ,Theranexus ,Bbdf ,Present ,Progress ,Thatten ,Program ,Translational ,Research ,Conference ,Management ,Cls ,November ,022 ,Chicago ,